FindTrial
Sign In

The analysis of serum metabolic components and gastric mucosa in patients with liver cirrhosis

The analysis of serum metabolic components and gastric mucosa in patients with liver cirrhosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100051070
Enrollment
Unknown
Registered
2021-09-11
Start date
2021-09-04
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver cirrhosis

Interventions

Control group:No
cirrhosis group:No

Sponsors

Department of Gastroenterology, Qilu Hospital, Cheloo College of Medicine, Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Experimental group: liver cirrhosis patients who have perfected electronic gastroscopy; 2. Control group: non-cirrhotic patients with perfect electronic gastroscopy.

Exclusion criteria

Exclusion criteria: 1. Those who received proton pump inhibitors, antibiotics, hormones, immunosuppressants or chemotherapy drugs within the past 1 month; 2. Patients with cardiovascular disease, diabetes, intestinal inflammatory disease, serious underlying disease, mental disease or other diseases; 3. Those who currently take microbial preparations, yogurt or other probiotics.

Design outcomes

Primary

MeasureTime frame
gastric microflora;The Analysis of serum metabolic components;oral microflora;gastric intestinal metaplasia;—

Countries

China

Contacts

Public ContactLi Zhen

Qilu Hospital of Shandong University

308077828@qq.com+86 18560086106

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 8, 2026